The treatment of cold tumors with Vps34 inhibitors induces the release of inflammatory chemokines such as CCL5 and CXCL10 in tumor cells, resulting in homing of natural killer (NK) and CD8+ T cells to the tumor microenvironment [9]. Here, CCL5 is linked to neoplasm.